Is ASML Stock a Buy Now?

ASML, a critical supplier of EUV lithography equipment for advanced AI semiconductor manufacturing, saw its stock rebound to a 52-week high in September following an easing of geopolitical pressures and a positive outlook from JPMorgan. Despite anticipated reduced revenue from China, the company projects 15% year-over-year sales growth for 2025, underpinned by its monopolistic technology, robust financials including a decade of EPS growth, and indispensable role in the burgeoning AI chip market, suggesting a strong long-term investment profile.

Analysis

ASML demonstrated a significant stock rebound in September, reaching a 52-week high of $938.68 after a JPMorgan Chase note suggested geopolitical pressures were subsiding. This recovery counters earlier stock depression caused by updated regulations restricting sales to China, a market expected to shrink from over a third of revenue in 2024 to approximately 25% in 2025. Despite this headwind, the company projects a robust 15% year-over-year sales growth for 2025, underpinned by its technological monopoly in extreme ultraviolet (EUV) lithography systems, which are indispensable for advanced AI semiconductor manufacturing. The company's financial health is strong, as evidenced by its fiscal Q2 results: net income rose to 2.3 billion euros from 1.6 billion year-over-year, gross margin expanded to 53.7% from 51.5%, and net bookings stood at 5.5 billion euros. Furthermore, a solid balance sheet with 7.2 billion euros in cash and a decade-long history of increasing EPS highlight its operational and financial discipline. Although the stock price is elevated, its price-to-earnings ratio is considered reasonable compared to the previous year, suggesting the valuation has not become overly stretched.

Key Decisions for Investors

• Investors should recognize that ASML's monopolistic control over EUV lithography technology provides a durable competitive advantage and a strong secular growth driver tied to the AI industry, justifying a long-term bullish outlook despite the stock's recent appreciation.
• Monitor revenue concentration in China and any new geopolitical or trade policy developments, as these remain the primary risks to the company's forecasted 15% sales growth for 2025.
• Despite the stock trading at a 52-week high, the reasonable P/E valuation relative to its historical levels suggests that the current price may still represent a viable entry point for a high-quality, long-term holding.